479 related articles for article (PubMed ID: 14716740)
1. Functional and anatomical effects of hormonally induced experimental prostate growth: a urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
Yokota T; Honda K; Tsuruya Y; Nomiya M; Yamaguchi O; Gotanda K; Constantinou CE
Prostate; 2004 Feb; 58(2):156-63. PubMed ID: 14716740
[TBL] [Abstract][Full Text] [Related]
2. New urodynamic model to explain micturition disorders in benign prostatic hyperplasia patients. Pressure-flow relationships in collapsable tubes, hydraulic analysis of the urethra and evaluation of urethral resistance.
Glemain P; Buzelin JM; Cordonnier JP
Eur Urol; 1993; 24 Suppl 1():12-7. PubMed ID: 7687552
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the relative biomechanical effects of alpha 1 and alpha 2 antagonists in modifying the compliance of the prostate and micturition parameters of the hormonally manipulated male rat.
Constantinou CE; Omata S
Neurourol Urodyn; 1996; 15(1):85-101. PubMed ID: 8696360
[TBL] [Abstract][Full Text] [Related]
4. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
5. Chronology and urodynamic characterization of micturition in neurohormonally induced experimental prostate growth in the rat.
Lee JZ; Omata S; Tillig B; Perkash I; Constantinou CE
Neurourol Urodyn; 1998; 17(1):55-69. PubMed ID: 9453692
[TBL] [Abstract][Full Text] [Related]
6. Influence of hormone treatment on prostate growth and micturition characteristics of the rat.
Constantinou CE
Prostate; 1996 Jul; 29(1):30-5. PubMed ID: 8685052
[TBL] [Abstract][Full Text] [Related]
7. Data from frequency-volume charts versus maximum free flow rate, residual volume, and voiding cystometric estimated urethral obstruction grade and detrusor contractility grade in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Van Venrooij GE; Eckhardt MD; Boon TA
Neurourol Urodyn; 2002; 21(5):450-6. PubMed ID: 12232879
[TBL] [Abstract][Full Text] [Related]
8. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
9. Age related urodynamic changes in patients with benign prostatic hyperplasia.
Madersbacher S; Klingler HC; Schatzl G; Stulnig T; Schmidbauer CP; Marberger M
J Urol; 1996 Nov; 156(5):1662-7. PubMed ID: 8863566
[TBL] [Abstract][Full Text] [Related]
10. Challenging the maximum flow rate: a new index of voiding dysfunction in men with benign prostatic enlargement.
Valentini FA; Nelson PP; Besson GR; Zimmern PE
BJU Int; 2008 Apr; 101(8):995-9. PubMed ID: 18241248
[TBL] [Abstract][Full Text] [Related]
11. [Contribution of pressure-flow relationship studies in the evaluation of benign hypertrophy of the prostate].
Haab F
Prog Urol; 1999 Feb; 9(1):151-5. PubMed ID: 10212970
[TBL] [Abstract][Full Text] [Related]
12. Modelized analysis of pressure-flow studies of patients with lower urinary tract symptoms due to benign prostatic enlargement.
Valentini FA; Zimmern PE; Besson GR; Nelson PP
Neurourol Urodyn; 2003; 22(1):45-53. PubMed ID: 12478601
[TBL] [Abstract][Full Text] [Related]
13. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
[TBL] [Abstract][Full Text] [Related]
14. Clinical and experimental studies of benign prostatic hyperplasia.
Coffey DS; Walsh PC
Urol Clin North Am; 1990 Aug; 17(3):461-75. PubMed ID: 1695775
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology and differential diagnosis of benign prostatic hypertrophy.
Blaivas JG
Urology; 1988 Dec; 32(6 Suppl):5-11. PubMed ID: 2462303
[TBL] [Abstract][Full Text] [Related]
16. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.
Tanaka Y; Masumori N; Itoh N; Sato Y; Takahashi A; Ogura H; Furuya S; Tsukamoto T
J Urol; 2002 Jun; 167(6):2492-5. PubMed ID: 11992065
[TBL] [Abstract][Full Text] [Related]
17. Effects of retrospective quality control on pressure-flow data with computer-based urodynamic systems from men with benign prostatic hyperplasia.
Liao LM; Schaefer W
Asian J Androl; 2007 Nov; 9(6):771-80. PubMed ID: 17968462
[TBL] [Abstract][Full Text] [Related]
18. Influence of bladder outlet obstruction and detrusor contractility on residual urine in patients with benign prostatic hyperplasia.
Zhang P; Wu Z; Gao J
Chin Med J (Engl); 2003 Oct; 116(10):1508-10. PubMed ID: 14570611
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term administration of androgens and estrogen on rhesus monkey prostate: possible induction of benign prostatic hyperplasia.
Jeyaraj DA; Udayakumar TS; Rajalakshmi M; Pal PC; Sharma RS
J Androl; 2000; 21(6):833-41. PubMed ID: 11105909
[TBL] [Abstract][Full Text] [Related]
20. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
Hamann MF; Naumann CM; Seif C; van der Horst C; Jünemann KP; Braun PM
Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
